Cargando…
P1457: DEMOGRAPHICS AND TREATMENT OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH OFF-THE-SHELF EBV-SPECIFIC CTL (TABELECLEUCEL) UNDER AN ONGOING EXPANDED ACCESS PROGRAM IN EUROPE: FIRST ANALYSES
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429700/ http://dx.doi.org/10.1097/01.HS9.0000848684.24968.42 |
| _version_ | 1784779540530200576 |
|---|---|
| author | Choquet, S. Uttenthal, B. Chaganti, S. Comoli, P. Trappe, R. Friedetzky, A. Xing, B. Li, X. Polak, T. Gamelin, L. Terwey, J.-H. Dierickx, D. |
| author_facet | Choquet, S. Uttenthal, B. Chaganti, S. Comoli, P. Trappe, R. Friedetzky, A. Xing, B. Li, X. Polak, T. Gamelin, L. Terwey, J.-H. Dierickx, D. |
| author_sort | Choquet, S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429700 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94297002022-08-31 P1457: DEMOGRAPHICS AND TREATMENT OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH OFF-THE-SHELF EBV-SPECIFIC CTL (TABELECLEUCEL) UNDER AN ONGOING EXPANDED ACCESS PROGRAM IN EUROPE: FIRST ANALYSES Choquet, S. Uttenthal, B. Chaganti, S. Comoli, P. Trappe, R. Friedetzky, A. Xing, B. Li, X. Polak, T. Gamelin, L. Terwey, J.-H. Dierickx, D. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429700/ http://dx.doi.org/10.1097/01.HS9.0000848684.24968.42 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Choquet, S. Uttenthal, B. Chaganti, S. Comoli, P. Trappe, R. Friedetzky, A. Xing, B. Li, X. Polak, T. Gamelin, L. Terwey, J.-H. Dierickx, D. P1457: DEMOGRAPHICS AND TREATMENT OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH OFF-THE-SHELF EBV-SPECIFIC CTL (TABELECLEUCEL) UNDER AN ONGOING EXPANDED ACCESS PROGRAM IN EUROPE: FIRST ANALYSES |
| title | P1457: DEMOGRAPHICS AND TREATMENT OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH OFF-THE-SHELF EBV-SPECIFIC CTL (TABELECLEUCEL) UNDER AN ONGOING EXPANDED ACCESS PROGRAM IN EUROPE: FIRST ANALYSES |
| title_full | P1457: DEMOGRAPHICS AND TREATMENT OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH OFF-THE-SHELF EBV-SPECIFIC CTL (TABELECLEUCEL) UNDER AN ONGOING EXPANDED ACCESS PROGRAM IN EUROPE: FIRST ANALYSES |
| title_fullStr | P1457: DEMOGRAPHICS AND TREATMENT OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH OFF-THE-SHELF EBV-SPECIFIC CTL (TABELECLEUCEL) UNDER AN ONGOING EXPANDED ACCESS PROGRAM IN EUROPE: FIRST ANALYSES |
| title_full_unstemmed | P1457: DEMOGRAPHICS AND TREATMENT OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH OFF-THE-SHELF EBV-SPECIFIC CTL (TABELECLEUCEL) UNDER AN ONGOING EXPANDED ACCESS PROGRAM IN EUROPE: FIRST ANALYSES |
| title_short | P1457: DEMOGRAPHICS AND TREATMENT OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH OFF-THE-SHELF EBV-SPECIFIC CTL (TABELECLEUCEL) UNDER AN ONGOING EXPANDED ACCESS PROGRAM IN EUROPE: FIRST ANALYSES |
| title_sort | p1457: demographics and treatment outcomes in patients with ebv+ ptld treated with off-the-shelf ebv-specific ctl (tabelecleucel) under an ongoing expanded access program in europe: first analyses |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429700/ http://dx.doi.org/10.1097/01.HS9.0000848684.24968.42 |
| work_keys_str_mv | AT choquets p1457demographicsandtreatmentoutcomesinpatientswithebvptldtreatedwithofftheshelfebvspecificctltabelecleucelunderanongoingexpandedaccessprogramineuropefirstanalyses AT uttenthalb p1457demographicsandtreatmentoutcomesinpatientswithebvptldtreatedwithofftheshelfebvspecificctltabelecleucelunderanongoingexpandedaccessprogramineuropefirstanalyses AT chagantis p1457demographicsandtreatmentoutcomesinpatientswithebvptldtreatedwithofftheshelfebvspecificctltabelecleucelunderanongoingexpandedaccessprogramineuropefirstanalyses AT comolip p1457demographicsandtreatmentoutcomesinpatientswithebvptldtreatedwithofftheshelfebvspecificctltabelecleucelunderanongoingexpandedaccessprogramineuropefirstanalyses AT trapper p1457demographicsandtreatmentoutcomesinpatientswithebvptldtreatedwithofftheshelfebvspecificctltabelecleucelunderanongoingexpandedaccessprogramineuropefirstanalyses AT friedetzkya p1457demographicsandtreatmentoutcomesinpatientswithebvptldtreatedwithofftheshelfebvspecificctltabelecleucelunderanongoingexpandedaccessprogramineuropefirstanalyses AT xingb p1457demographicsandtreatmentoutcomesinpatientswithebvptldtreatedwithofftheshelfebvspecificctltabelecleucelunderanongoingexpandedaccessprogramineuropefirstanalyses AT lix p1457demographicsandtreatmentoutcomesinpatientswithebvptldtreatedwithofftheshelfebvspecificctltabelecleucelunderanongoingexpandedaccessprogramineuropefirstanalyses AT polakt p1457demographicsandtreatmentoutcomesinpatientswithebvptldtreatedwithofftheshelfebvspecificctltabelecleucelunderanongoingexpandedaccessprogramineuropefirstanalyses AT gamelinl p1457demographicsandtreatmentoutcomesinpatientswithebvptldtreatedwithofftheshelfebvspecificctltabelecleucelunderanongoingexpandedaccessprogramineuropefirstanalyses AT terweyjh p1457demographicsandtreatmentoutcomesinpatientswithebvptldtreatedwithofftheshelfebvspecificctltabelecleucelunderanongoingexpandedaccessprogramineuropefirstanalyses AT dierickxd p1457demographicsandtreatmentoutcomesinpatientswithebvptldtreatedwithofftheshelfebvspecificctltabelecleucelunderanongoingexpandedaccessprogramineuropefirstanalyses |